Cargando…
Pros and Cons of Skeletal Medications in the COVID-19 Era
PURPOSE OF REVIEW: This review provides an overview regarding osteoporosis therapies during the COVID-19 pandemic. RECENT FINDINGS: The COVID-19 pandemic has disrupted treatments for osteoporosis and resulted in decreased adherence particularly for parenteral regimens. Osteoporosis medications are s...
Autores principales: | Tsourdi, Elena, Drake, Matthew T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287705/ https://www.ncbi.nlm.nih.gov/pubmed/35875832 http://dx.doi.org/10.1007/s40674-022-00192-7 |
Ejemplares similares
-
Remote Management of Osteoporosis
por: Saag, Jordan L., et al.
Publicado: (2022) -
Patients with osteoporosis: children of a lesser god
por: Adami, Giovanni, et al.
Publicado: (2023) -
Convivir con la osteoporosis /
por: Díaz Curiel, Manuel
Publicado: (2004) -
Inflammatory Rheumatic Disorders and Bone
por: Bultink, Irene E. M., et al.
Publicado: (2012) -
Optimising both disease control and glucocorticoid dosing is essential for bone protection in patients with rheumatic disease
por: Wiebe, Edgar, et al.
Publicado: (2022)